文献速递腹部技术与安全CT

腹部CT按去脂体重与总体重计算碘对比剂剂量:一项分层随机对照试验

Dosing Iodinated Contrast Media According to Lean Versus Total Body Weight at Abdominal CT: A Stratified Randomized Controlled Trial.
PubMed 文献 · Acad Radiol · 2019-08-19

该分层随机对照研究将280例门诊腹部CT患者分配至按总体重或去脂体重计算碘对比剂剂量组,比较肝脏强化指标。结果显示两组在按碘剂量和按体重归一化的肝脏强化指数上幅度及个体间变异均无显著差异,总体重组对比剂用量更多。

要点

  • 按总体重与去脂体重计算碘对比剂剂量,肝脏强化归一化指数幅度无显著差异。
  • 两组间肝脏强化指数的个体间变异均无显著差异(p>0.05)。
  • 总体重组对比剂用量多于去脂体重组:男性106.5±20 mL vs 98.4±11 mL,女性93.7±20 mL vs 77.5±11 mL。

核心结论

  • 按总体重和去脂体重计算对比剂剂量在常规腹部CT中产生的归一化平均肝脏强化指数幅度及个体间变异相似。

研究设计与样本

  • 伦理批准的分层随机对照研究,2018年2月至11月纳入280例门诊腹部CT患者,按计算机生成表格分配至总体重或去脂体重剂量组,固定35秒注射碘海醇350后门静脉期采集。

关键影像表现/征象

  • 肝脏强化值通过感兴趣区获取,比较归一化至碘剂量的平均肝脏强化指数(MHE/I)和归一化至每公斤总体重碘剂量的平均肝脏强化指数(aMHE)。
  • MHE/I女性总体重组1.75±0.5 HU/g vs 去脂体重组1.86±0.6 HU/g(p=0.31),男性1.53±0.4 HU/g vs 1.52±0.4 HU/g(p=0.90)。
  • aMHE女性总体重组0.03±0.01 HU/g/kg vs 去脂体重组0.03±0.01 HU/g/kg(p=0.25),男性0.02±0.01 HU/g/kg vs 0.02±0.01 HU/g/kg(p=0.52)。
  • MHE/I和aMHE的方差在所有组间均无显著差异(p>0.05)。

诊断标准与关键数值

  • 总体重组剂量:1.22 mL/kg。
  • 去脂体重组剂量:女性1.66 mL/kg去脂体重,男性1.52 mL/kg去脂体重。
  • 对比剂用量:男性总体重组106.5±20 mL vs 去脂体重组98.4±11 mL(p=0.007);女性总体重组93.7±20 mL vs 去脂体重组77.5±11 mL(p<0.0001)。

临床应用与阅片要点

  • 按总体重或去脂体重计算碘对比剂剂量均可用于常规腹部CT门静脉期肝脏强化评估。
  • 去脂体重方案可减少对比剂用量,但归一化肝脏强化指数与总体重方案相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To compare the magnitude and interpatient variability in normalized mean hepatic enhancement (MHE) indices when dosing contrast media (CM) according to total body weight (TBW) and lean body weight (LBW).

MATERIALS AND METHODS: This ethics-approved stratified randomized controlled study allocated 280 outpatients for abdominal Computed Tomography (CT) between February-November 2018 to TBW- or LBW-dosing using computer-generated tables. CTs were acquired in portal venous phase after fixed 35-second injection of Iohexol 350. Patients with missing precontrast image, incorrect dose, or chronic kidney, liver or heart disease were excluded. The number of included patients and CM doses were: TBW arm, 51 women and 60 men, 1.22 mL/kg; LBW arm, 59 women, 1.66 mL/kg LBW, and 59 men, 1.52 mL/kg LBW. Liver attenuations were obtained from regions of interest. Values and standard deviations in MHE indices normalized to iodine dose (MHE/I) and iodine dose per kg TBW (aMHE = MHE/[I/TBW]) were compared (unpaired t tests and F-tests).

RESULTS: Cohorts were similar in age, sex, TBW, and LBW. TBW groups received more CM than LBW groups: men, 106.5 ± 20 versus 98.4 ± 11 mL, p = 0.007; women, 93.7 ± 20 versus 77.5 ± 11 mL, p < 0.0001. TBW and LBW groups showed no significant difference in MHE/I (women, 1.75 ± 0.5 versus 1.86 ± 0.6 HU/g, p = 0.31; men, 1.53 ± 0.4 versus 1.52 ± 0.4 HU/g, p = 0.90) or aMHE (women, 0.03 ± 0.01 versus 0.03 ± 0.01 HU/g/kg, p = 0.25; men, 0.02 ± 0.01 versus 0.02 ± 0.01 HU/g/kg, p = 0.52). Variances in MHE/I and aMHE were not significantly different for all groups (p > 0.05).

CONCLUSION: TBW- and LBW-based CM dosing yield a similar magnitude and interpatient variability in normalized MHE indices at routine abdominal CT.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Costa AF, Peet K, Abdolell M, et al. Dosing Iodinated Contrast Media According to Lean Versus Total Body Weight at Abdominal CT: A Stratified Randomized Controlled Trial. Acad Radiol. 2019. PMID: 31439467. doi:10.1016/j.acra.2019.07.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。